NUTRACEUTICAL INTERNATIONAL CORP — Revenue by Fiscal Year
8 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/5a372547-dd39-4d99-8dc6-44ce9e1606e9/serie/revenue
| Fiscal year | Revenue | Period | Evidence |
|---|---|---|---|
| FY 2016 | $233.0M | 2015-10-01 – 2016-09-30 | evidence 0001050007-16-000015 |
| FY 2015 | $216.5M | 2014-10-01 – 2015-09-30 | evidence 0001047469-15-008809 |
| FY 2014 | $214.5M | 2013-10-01 – 2014-09-30 | evidence 0001047469-14-009431 |
| FY 2013 | $208.4M | 2012-10-01 – 2013-09-30 | evidence 0001047469-13-010881 |
| FY 2012 | $200.4M | 2011-10-01 – 2012-09-30 | evidence 0001047469-12-010736 |
| FY 2011 | $188.1M | 2010-10-01 – 2011-09-30 | evidence 0001047469-11-010134 |
| FY 2010 | $180.1M | 2009-10-01 – 2010-09-30 | evidence 0001047469-11-010134 |
| FY 2009 | $162.3M | 2008-10-01 – 2009-09-30 | evidence 0001047469-11-010134 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
NUTRACEUTICAL INTERNATIONAL CORP — all facts · Operating Income